Iodixanol

Stomach Cancer

Brian Henick, MDSmall moleculePhase 1Active

CC

41/ 100

Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence: 28/ 100
Competitive Position: 81/ 100

Competitive context

13 Active assets in the Stomach Cancer cohort.

Asset / Sponsor	Phase	Rating
Rivaroxaban Asan Medical Center	Phase 2	CCC
Apixaban Asan Medical Center	Phase 2	CCC
Fragmin Asan Medical Center	Phase 2	CCC
3h-10000 3H Pharmaceuticals Co., Ltd.	Phase 1/2	CC
Alpelisib Seoul National University Bundang Hospital	Phase 1/2	CC

View all 20 →

Same molecule, other indications

Iodixanol is also rated in:

carotid stenosisDormant

B

Indicative ·

63 / 100

atherosclerosisDormant

B

Indicative ·

62 / 100

Colon CancerDormant

B

Indicative ·

59 / 100

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.